Remove 2019 Remove Data Remove Download Remove Safety
article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 59
article thumbnail

Use Cannabis? Spotlight on Driving Unimpaired

Cannabis Law Report

In her October 13, 2019 Sun Sentinel article Pulled over with medical marijuana? 5, 2019 memo. Lab operator Brown said he would never drive with a CBD/hemp product without its “certificate of analysis,” which can be downloaded from the manufacturer or from his lab site at ACSLabCannabis.com. AUTHOR: Heather Allman.

Hemp 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

We also provide free downloadable resources: ‘The Endocannabinoid System and Medical Marijuana in 15 minutes!’ For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. Published 2019 May 6.

article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.fda.gov/media/131878/download.

CBD 144
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2016 ; Sznitman et al.

article thumbnail

Introducing AJEM- The American Jnl Of Endocannabinoid Medicine – Read Issue 1 For FREE

Cannabis Law Report

AJEM’s mission is to create, collect, and disseminate credible cannabis research data. The FDA held the first public hearing about cannabis on May 31, 2019. The FDA reopened the public comment period through September 30, 2019. Accessed October 12, 2019. March 22, 2019: R44742. Public Hearing May 31, 2019.

article thumbnail

USDA, FDA and EPA Called Before Congress to Report on Implementation of Hemp and CBD Regulations

Greenspoon Marder Cannabis Law Group Blog

FDA repeated that there is not enough data to move forward and that the agency would give a status report in the fall. Download Testimony. Assistant Administrator, Office of Chemical Safety and Pollution Prevention. Download Testimony. Download Testimony. Department of Agriculture. Washington, D.C.

Hemp 80